Most of the genes associated with the “regulation of lymphocyte proliferation” (including SOX11) were downregulated, supporting the phenotypic observation in mice with grafted Granta-519 MCL tumors that DPN treatment impaired tumor growth by affecting lymphoma cell proliferation (Figure 1B). Here, SOX11 is linked to lymphoma.